Skip to main content
. Author manuscript; available in PMC: 2012 Oct 1.
Published in final edited form as: Cancer. 2011 Oct 1;117(19):4424–4438. doi: 10.1002/cncr.26073

Figure 1. Antiproliferative activities of demethylating agents and histone deacetylase inhibitors on ovarian cancer cells.

Figure 1

(A) Hey or (B) SKOv3 cells were treated with indicated concentrations of demethylating agents (DAC, AZA) and HDAC inhibitors (SAHA, TSA), individually or in combinations. Cell proliferation was determined on day 5 with SRB assays. Data plotted represent optical density of SRB stained cells treated with the different agents normalized to values for untreated control cells.